4//SEC Filing
Williams Lewis T 4
Accession 0001209191-19-036513
CIK 0001175505other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 6:28 PM ET
Size
5.5 KB
Accession
0001209191-19-036513
Insider Transaction Report
Form 4
Williams Lewis T
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2019-06-10+15,000→ 15,000 totalExercise: $6.09Exp: 2029-06-09→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]This option will vest in its entirety on the earlier to occur of (i) June 10, 2020 or (ii) the day before the 2020 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date.
Documents
Issuer
FIVE PRIME THERAPEUTICS INC
CIK 0001175505
Entity typeother
Related Parties
1- filerCIK 0001475714
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 6:28 PM ET
- Size
- 5.5 KB